SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-08-006559
Filing Date
2008-10-20
Accepted
2008-10-20 17:14:31
Documents
5
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 CRITICAL THERAPEUTICS, INC. b72572cte10vq.htm 10-Q 558648
2 EX-31.1 SECTION 302 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER b72572ctexv31w1.htm EX-31.1 8667
3 EX-31.2 SECTION 302 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER b72572ctexv31w2.htm EX-31.2 8725
4 EX-32.1 SECTION 906 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER b72572ctexv32w1.htm EX-32.1 3648
5 EX-32.2 SECTION 906 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER b72572ctexv32w2.htm EX-32.2 3745
  Complete submission text file 0000950135-08-006559.txt   584820
Mailing Address 60 WESTVIEW STREET LEXINGTON MA 02421
Business Address 60 WESTVIEW STREET LEXINGTON MA 02421 781-402-5700
CRITICAL THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50767 | Film No.: 081132009
SIC: 2834 Pharmaceutical Preparations